These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 11913718)

  • 1. Pharmacokinetics, stability, and blood partition of DA-8159, a new phosphodiesterase V inhibitor.
    Shim HJ; Lee EJ; Kim SH; Kim SH; Yoo M; Kwon JW; Kim WB; Lee HS; Lee MG
    Res Commun Mol Pathol Pharmacol; 2000; 108(3-4):275-86. PubMed ID: 11913718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics, blood partition and protein binding of DA-7867, a new oxazolidinone.
    Bae SK; Chung WS; Kim EJ; Rhee JK; Kwon JW; Kim WB; Lee MG
    Biopharm Drug Dispos; 2004 Apr; 25(3):127-35. PubMed ID: 15083501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics, stability, and blood partition of 7-anilino-5,8-isoquinolinedione, a new isoquinonlinedione derivative.
    Kim SH; Moon YJ; Ryu CK; Lee MG
    Res Commun Mol Pathol Pharmacol; 2000; 107(5-6):419-29. PubMed ID: 11589368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic changes of DA-8159, a new erectogenic, after intravenous and oral administration to rats with acute renal failure induced by uranyl nitrate.
    Shim HJ; Kim YC; Kim EJ; Kim DG; Kwon JW; Kim WB; Lee MG
    Biopharm Drug Dispos; 2004 Apr; 25(3):137-42. PubMed ID: 15083502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stability, tissue metabolism, tissue distribution, and blood partition of DA-1131, a new carbapenem.
    Kim SH; Kim WB; Lee MG
    Res Commun Mol Pathol Pharmacol; 1995 Dec; 90(3):347-62. PubMed ID: 8746482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stability, blood partition, and pharmacokinetics of a new proton pump inhibitor, YJA-20379-8.
    Chung SY; Han KS; Chung YK; Chang MS; Lee MG
    Res Commun Mol Pathol Pharmacol; 1998 May; 100(2):187-200. PubMed ID: 9667073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of pharmacokinetics of M1, M2, M3, and M4 after intravenous administration of DA-125 or ME2303 to mice and rats. New adriamycin analogues containing fluorine.
    Yoon EJ; Lee WI; Shim HJ; Lee SD; Kim WB; Yang J; Lee MG
    Biopharm Drug Dispos; 1996 Jul; 17(5):373-420. PubMed ID: 8830976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro metabolism of a novel phosphodiesterase-5 inhibitor DA-8159 in rat liver preparations using liquid chromatography/electrospray mass spectrometry.
    Choi SJ; Ji HY; Lee HY; Kim DS; Kim WB; Lee HS
    Biomed Chromatogr; 2002 Sep; 16(6):395-9. PubMed ID: 12228896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics, blood partition, and tissue distribution of itraconazole.
    Lee JH; Shin JH; Lee MG
    Res Commun Mol Pathol Pharmacol; 2004; 115-116():203-15. PubMed ID: 17564318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stability, blood partition, and pharmacokinetics of a new reversible proton pump inhibitor, YJA-20379-1.
    Kim SH; Han KS; Choi WS; Chang MS; Lee MG
    Res Commun Mol Pathol Pharmacol; 1997 Oct; 98(1):77-84. PubMed ID: 9434317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subacute toxicities and toxicokinetics of DA-8159, a new phosphodiesterase type V inhibitor, after single and 4-week repeated oral administration in rats.
    Shim HJ; Kim YC; Jang JM; Park KJ; Kim DH; Kang KK; Ahn BO; Kwon JW; Kim WB; Lee MG
    Biopharm Drug Dispos; 2003 Dec; 24(9):409-18. PubMed ID: 14689469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of DA-8159, a new erectogenic, administered at 10:00 h versus 22:00 h in rats.
    Lee JH; Kim YC; Kwon JW; Kim WB; Lee MG
    Int J Pharm; 2005 May; 296(1-2):94-102. PubMed ID: 15885460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic treatment of DA-8159, a new phosphodiesterase type V inhibitor, attenuates endothelial dysfunction in stroke-prone spontaneously hypertensive rat.
    Choi SM; Kim JE; Kang KK
    Life Sci; 2006 Feb; 78(11):1211-6. PubMed ID: 16214180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic interaction between 5-[2-propyloxy-5-(1-methyl-2-pyrollidinylethylamidosulfonyl)phenyl]-1-methyl-3-propyl-1,6-dihydro-7H-pyrazolo (4,3-d) pyrimidine-7-one (DA-8159) and nitroglycerin in rats.
    Lee SJ; Bae SK; Kwon JW; You M; Lee DC; Lee MG
    J Pharm Pharmacol; 2005 Nov; 57(11):1397-405. PubMed ID: 16259771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic administration of phosphodiesterase 5 inhibitor improves erectile and endothelial function in a rat model of diabetes.
    Ahn GJ; Yu JY; Choi SM; Kang KK; Ahn BO; Kwon JW; Kang SK; Lee BC; Hwang WS
    Int J Androl; 2005 Oct; 28(5):260-6. PubMed ID: 16128985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of DA-8159, a novel PDE5 inhibitor, on erectile function in the rat model of hypercholesterolemic erectile dysfunction.
    Kang KK; Yu JY; Yoo M; Kwon JW
    Int J Impot Res; 2005; 17(5):409-16. PubMed ID: 15920460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and tissue distribution of a novel PDE5 inhibitor, SK-3530, in rats.
    Yoo HH; Kim NS; Im GJ; Kim DH
    Acta Pharmacol Sin; 2007 Aug; 28(8):1247-53. PubMed ID: 17640490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensitive liquid chromatography assay with ultraviolet detection for a new phosphodiesterase V inhibitor, DA-8159, in human plasma and urine.
    Cho JY; Lim HS; Yu KS; Shim HJ; Jang IJ; Shin SG
    J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Oct; 795(2):179-86. PubMed ID: 14522022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stability, blood partition and protein binding of an antifibrotic agent, oltipraz.
    Bu SC; Kim EJ; Kim SH; Kim SG; Lee MG
    Res Commun Mol Pathol Pharmacol; 2001; 109(5-6):333-44. PubMed ID: 12889516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of bacterial lipopolysaccharide on the pharmacokinetics of DA-8159, a new erectogenic, in rats.
    Lee JH; Kim YC; Kwon JW; Kim WB; Lee MG
    Res Commun Mol Pathol Pharmacol; 2005; 117-118():179-87. PubMed ID: 18426088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.